Related Experiment Videos
[Pathogenesis of systemic scleroderma: immunological aspects]
Luc Mouthon1, Paloma García De La Peña-Lefebvre, Youri Chanseaud
1Service de Médecine Interne, Hôpital Avicenne, Assistance Public, Hôpitaux de Paris, et Université Paris Nord, 125, route de Stalingrad, 93009 Bobigny.
Annales De Medecine Interne
|September 10, 2002
Summary
Systemic sclerosis (SSc) involves abnormal fibroblast activity and immune cell interactions, leading to excessive collagen production. Early immunological changes and specific autoantibodies are key features of this connective tissue disorder.
Area of Science:
- Immunology
- Cell Biology
- Rheumatology
Context:
- Systemic sclerosis (SSc) is a connective tissue disease marked by excessive collagen synthesis, vascular issues, and immune system abnormalities.
- Fibroblast activation and collagen production in SSc result from complex interactions involving endothelial cells, fibroblasts, and mononuclear cells.
Purpose:
- To elucidate the immunological underpinnings of Systemic Sclerosis (SSc).
- To explore the role of cytokines and T lymphocytes in fibroblast activation and collagen synthesis in SSc.
- To identify key autoantibodies associated with SSc and their prognostic significance.
Summary:
- Mononuclear cells, particularly macrophages and T lymphocytes, drive fibroblast activation and collagen synthesis in SSc through cytokine production.
- CD8+ T lymphocytes in SSc lesions produce Interleukin-4 (IL-4), which, along with TGF-B and CTGF, promotes collagen synthesis.
- While gamma interferon (INF-gamma) inhibits collagen synthesis, its effect is reduced in SSc patients. Specific autoantibodies like anti-centromere, anti-Scl70, and anti-RNA polymerase III are diagnostic and prognostic markers.
Impact:
- Understanding the immunological mechanisms in SSc can lead to targeted therapies for fibroblast activation and fibrosis.
- Identification of specific autoantibodies aids in disease classification, prognosis prediction, and potentially monitoring treatment response.
- This research highlights the critical interplay between the immune system and fibrotic processes in Systemic Sclerosis, paving the way for novel therapeutic strategies.